Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022

  • ID: 4470016
  • Report
  • Region: Global
  • 138 Pages
  • Markets and Markets
1 of 6
Injection Pen Market worth 41.38 Billion USD by 2022

FEATURED COMPANIES

  • Astrazeneca
  • ELI Lilly and Company
  • F.Hoffman-La Roche
  • Haselmeier
  • Merck
  • Novartis
  • MORE

“The injection pen market is projected to grow at a CAGR of 6.0% during the forecast period”

The global injection pen market is expected to reach USD 41.38 billion by 2022 from an estimated USD 30.97 billion in 2017, at a CAGR of 6.0% during the forecast period. Growing prevalence of chronic diseases across the globe, increasing number of regulatory approvals, and favorable reimbursements are expected to drive the growth of the injection pen market. However, preference for alternative drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of this market to a certain extent.

“By type, the disposable injection pens segment is expected to grow at the highest rate during the forecast period (2017-2022).”

Based on type, the market is segmented into disposable and reusable injection pens. The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the benefits that these pens offer, such as portability, ease of use, and a lower possibility of infection.

“By therapy, the diabetes segment is expected to grow at the highest CAGR during the study period.”

Based on therapy, the global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies. The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of the segment can be primarily attributed to the large diabetic population and favorable reimbursements for diabetic treatments in developed countries. The diabetes segment is further segmented into Insulin and GLP-1.

“The North American injection pen market is expected to grow at the highest CAGR during the forecast period”

North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to the rising prevalence of diabetes in the US and Canada, a favorable reimbursement scenario, and the increasing number of awareness programs in that region.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-50%, Tier 2-30% and Tier 3-20%
  • By Designation - C-level-30%, Director Level-48%, Others-22%
  • By Region - North America-48%, Europe-20%, Asia Pacific-25%, Row-7%

The key players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).

Research Coverage:

The report analyzes the injection pen market and aims at estimating the market size and future growth potential of this market based on various segments such as type, therapy, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the injection pen market. The report analyzes the market based on type, therapy, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the injection pen market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various injection pens across regions
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the injection pen market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Astrazeneca
  • ELI Lilly and Company
  • F.Hoffman-La Roche
  • Haselmeier
  • Merck
  • Novartis
  • MORE

1 Introduction
1.1 Objectives of Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Design
2.2 Research Approach
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Global Injection Pen Market Overview
4.2 Global Market, By Type, 2017 vs 2022
4.3 Geographic Analysis: Global Market, By Therapy
4.4 Global Market, By End User, 2017 vs 2022
4.5 Geographic Snapshot: Global Injection Pen Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Chronic Diseases
5.2.1.2 Increasing Number of Regulatory Approvals
5.2.1.3 Favorable Reimbursement and Government Support
5.2.2 Restraints
5.2.2.1 Preference for Alternative Drug Delivery Modes
5.2.2.2 Poor Reimbursement Scenario in Developing Countries
5.2.3 Opportunities
5.2.3.1 Patent Expiry of Biologics to Drive the Demand for Biosimilars
5.2.4 Challenges
5.2.4.1 Needle-Stick Injuries & Misuse of Injection Pen

6 Injection Pen Market, By Type
6.1 Introduction
6.1.1 Disposable Injection Pen
6.1.2 Reusable Injection Pen

7 Injection Pen Market, By Therapy
7.1 Introduction
7.2 Diabetes
7.2.1 Insulin
7.2.2 Glucagon-Like Peptide-1 (GLP-1)
7.3 Growth Hormone Therapy
7.4 Osteoporosis
7.5 Fertility
7.6 Other Therapies

8 Injection Pen Market, By End User
8.1 Introduction
8.2 Home Care
8.3 Hospitals & Clinics

9 Injection Pen Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 UK
9.3.2 Germany
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 RoAPAC
9.5 RoW

10 Competitive Landscape
10.1 Overview
10.2 Market Ranking of OEM Companies
10.3 Market Share Analysis
10.4 Competitive Scenario
10.4.1 Product Launches
10.4.2 Regulatory Approvals
10.4.3 Expansions
10.4.4 Agreements, Collaborations, and Partnerships
10.4.5 Acquisitions

11 Company Profiles
(Business Overview, Products Offered, Recent Developments, Swot Analysis, Author's View)*
11.1 Novo Nordisk
11.2 Sanofi
11.3 Eli Lilly And Company
11.4 Merck
11.5 Ypsomed
11.6 Astrazeneca
11.7 F.Hoffman-La Roche
11.8 Becton, Dickinson And Company (Bd)
11.9 Owen Mumford
11.11 Novartis
11.12 Pfizer
11.13 Haselmeier
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, Author's View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables:
Table 1 Injection Pen Market, By Type, 2015-2022 (USD Million)
Table 2 Disposable Market, By Region, 2015-2022 (USD Million)
Table 3 Reusable Market, By Region, 2015-2022 (USD Million)
Table 4 Market, By Therapy, 2015-2022 (USD Million)
Table 5 Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 6 Injection Pen Market for Diabetes Therapy, By Region, 2015-2022 (USD Million)
Table 7 Market for Insulin Therapy, By Region, 2015-2022 (USD Million)
Table 8 Market for GLP-1 Therapy, By Region, 2015-2022 (USD Million)
Table 9 Market for Growth Hormone Therapy, By Region, 2015-2022 (USD Million)
Table 10 Injection Pen Market for Osteoporosis Therapy, By Region, 2015-2022 (USD Million)
Table 11 Market for Fertility Therapy, By Region, 2015-2022 (USD Million)
Table 12 Market for Other Therapies, By Region, 2015-2022 (USD Million)
Table 13 Market, By End User, 2015-2022 (USD Million)
Table 14 Injection Pen Market for Home Care, By Region, 2015-2022 (USD Million)
Table 15 Market for Hospitals & Clinics, By Region, 2015-2022 (USD Million)
Table 16 Market, By Region, 2015-2022 (USD Million)
Table 17 North America: Market, By Country, 2015-2022 (USD Million)
Table 18 North America: Injection Pen Market, By Type, 2015-2022 (USD Million)
Table 19 North America: Market, By Therapy, 2015-2022 (USD Million)
Table 20 North America: Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 21 North America: Market, By End User, 2015-2022 (USD Million)
Table 22 Fda Approvals of Injection Pen (2014-2017)
Table 23 US: Market, By Type, 2015-2022 (USD Million)
Table 24 US: Market, By Therapy, 2015-2022 (USD Million)
Table 25 US: Injection Pen Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 26 US: Market, By End User, 2015-2022 (USD Million)
Table 27 Canada: Market, By Type, 2015-2022 (USD Million)
Table 28 Canada: Market, By Therapy, 2015-2022 (USD Million)
Table 29 Canada: Injection Pen Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 30 Canada: Market, By End User, 2015-2022 (USD Million)
Table 31 Approvals of Injection Pen (2014-2017)
Table 32 Europe: Market, By Country, 2015-2022 (USD Million)
Table 33 Europe: Market, By Type, 2015-2022 (USD Million)
Table 34 Europe: Injection Pen Market, By Therapy, 2015-2022 (USD Million)
Table 35 Europe: Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 36 Europe: Injection Pen Market, By End User, 2015-2022 (USD Million)
Table 37 UK: Market, By Type, 2015-2022 (USD Million)
Table 38 UK: Market, By Therapy, 2015-2022 (USD Million)
Table 39 UK: Injection Pen Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 40 UK: Market, By End User, 2015-2022 (USD Million)
Table 41 Germany: Market, By Type, 2015-2022 (USD Million)
Table 42 Germany: Injection Pen Market, By Therapy, 2015-2022 (USD Million)
Table 43 Germany: Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 44 Germany: Market, By End User, 2015-2022 (USD Million)
Table 45 France: Market, By Type, 2015-2022 (USD Million)
Table 46 France: Injection Pen Market, By Therapy, 2015-2022 (USD Million)
Table 47 France: Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 48 France: Injection Pen Market, By End User, 2015-2022 (USD Million)
Table 49 RoE: Market, By Type, 2015-2022 (USD Million)
Table 50 RoE: Market, By Therapy, 2015-2022 (USD Million)
Table 51 RoE: Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 52 RoE: Injection Pen Market, By End User, 2015-2022 (USD Million)
Table 53 Asia Pacific: Market, By Country, 2015-2022 (USD Million)
Table 54 Asia Pacific: Market, By Type, 2015-2022 (USD Million)
Table 55 Asia Pacific: Market, By Therapy, 2015-2022 (USD Million)
Table 56 Asia Pacific: Injection Pen Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 57 Asia Pacific: Market, By End User, 2015-2022 (USD Million)
Table 58 China: Market, By Type, 2015-2022 (USD Million)
Table 59 China: Market, By Therapy, 2015-2022 (USD Million)
Table 60 China: Injection Pen Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 61 China: Market, By End User, 2015-2022 (USD Million)
Table 62 Japan: Market, By Type, 2015-2022 (USD Million)
Table 63 Japan: Market, By Therapy, 2015-2022 (USD Million)
Table 64 Japan: Injection Pen Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 65 Japan: Market, By End User, 2015-2022 (USD Million)
Table 66 India: Market, By Type, 2015-2022 (USD Million)
Table 67 India: Market, By Therapy, 2015-2022 (USD Million)
Table 68 India: Injection Pen Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 69 India: Market, By End User, 2015-2022 (USD Million)
Table 70 RoAPAC: Market, By Type, 2015-2022 (USD Million)
Table 71 RoAPAC: Market, By Therapy, 2015-2022 (USD Million)
Table 72 RoAPAC: Injection Pen Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 73 RoAPAC: Market, By End User, 2015-2022 (USD Million)
Table 74 RoW: Market, By Type, 2015-2022 (USD Million)
Table 75 RoW: Market, By Therapy, 2015-2022 (USD Million)
Table 76 RoW: Market for Diabetes Therapy, By Type, 2015-2022 (USD Million)
Table 77 RoW: Injection Pen Market, By End User, 2015-2022 (USD Million)
Table 78 Product Launches (2014-2017)
Table 79 Regulatory Approvals
Table 80 Expansions
Table 81 Agreements and Partnerships
Table 82 Acquisitions

List of Figures:
Figure 1 Research Design: Global Injection Pen Market
Figure 2 Global Market: Research Methodology Steps
Figure 3 Sampling Frame: Primary Insights
Figure 4 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Primary Sources
Figure 6 Key Industry Insights
Figure 7 Market Size Estimation Methodology: Bottom-Up Approach
Figure 8 Market Size Estimation Methodology: Top-Down Approach
Figure 9 Data Triangulation Methodology
Figure 10 Disposable Injection Pen Dominated the Market in 2017
Figure 11 Diabetes Segment Dominated the Injection Pen Market, By Therapy (2017)
Figure 12 Insulin Segment Dominated the Global Market for Diabetes, By Type (2017)
Figure 13 Home Care Segment Dominated the Market, By End User (2017)
Figure 14 North America is Slated to Witness the Highest Market Growth During the Forecast Period
Figure 15 Growing Prevalence of Chronic Diseases, Increasing Number of Regulatory Approvals, and Favorable Reimbursement and Government Support are Driving Market Growth
Figure 16 Disposable Injection Pen Segment Dominated the Market in 2017
Figure 17 Diabetes Therapy Dominated the Global Injection Pen Market in 2017
Figure 18 Home Care Accounted for the Largest Market Share in 2017
Figure 19 Asia Pacific to Witness the Highest Growth Rate During the Forecast Period
Figure 20 Market, By Type, 2017 vs 2022 (USD Million)
Figure 21 Injection Pen Market, By Therapy, 2017 vs 2022 (USD Million)
Figure 22 Market, By End User, 2017 vs 2022 (USD Million)
Figure 23 North America to Command the Largest Market Share in 2017
Figure 24 North America: Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 Asia Pacific: Market Snapshot
Figure 27 RoW: Market Snapshot
Figure 28 Global Injection Pen Market Ranking By OEM Companies (As of 2016)
Figure 29 Market Share, By Key Player, 2016
Figure 30 Strategies Adopted By Market Players (2014-2017)
Figure 31 Novo Nordisk: Company Snapshot (2016)
Figure 32 Sanofi: Company Snapshot (2016)
Figure 33 ELI Lilly and Company: Company Snapshot (2016)
Figure 34 Merck: Company Snapshot (2016)
Figure 35 Ypsomed: Company Snapshot (2016)
Figure 36 Astrazeneca: Company Snapshot (2016)
Figure 37 F.Hoffman-La Roche: Company Snapshot (2016)
Figure 38 BD: Company Snapshot (2016)
Figure 39 Novartis: Company Snapshot (2016)
Figure 40 Pfizer: Company Snapshot (2016)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Astrazeneca
  • Becton, Dickinson and Company (BD)
  • ELI Lilly and Company
  • F.Hoffman-La Roche
  • Haselmeier
  • Merck
  • Novartis
  • Novo Nordisk
  • Owen Mumford
  • Pfizer
  • Sanofi
  • Ypsomed
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll